Literature DB >> 8660111

Effect of isradipine on endothelin-1 plasma concentrations in patients with Raynaud's phenomenon.

L La Civita, D Giuggioli, M G Del Chicca, G Longombardo, G Pasero, C Ferri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8660111      PMCID： PMC1010174          DOI： 10.1136/ard.55.5.331-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

1.  Increased plasma endothelin levels in patients with Raynaud's phenomenon.

Authors:  M L Biondi; B Marasini; C Bassani; A Agastoni
Journal:  N Engl J Med       Date:  1991-04-18       Impact factor: 91.245

2.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

Review 3.  Endothelins.

Authors:  E R Levin
Journal:  N Engl J Med       Date:  1995-08-10       Impact factor: 91.245

Review 4.  Raynaud's syndrome, an enigma after 130 years.

Authors:  T J Cleophas; M G Niemeyer
Journal:  Angiology       Date:  1993-03       Impact factor: 3.619

5.  Treatment of Raynaud's phenomenon.

Authors:  H Wollersheim; P A van Zwieten
Journal:  Eur Heart J       Date:  1993-02       Impact factor: 29.983

6.  Plasma levels of endothelin-1 in mixed cryoglobulinaemia patients.

Authors:  C Ferri; L La Civita; A L Zignego; G Longombardo; M G Del Chicca; R Pedrinelli; F Greco; G Pasero; S Bombardieri
Journal:  Br J Rheumatol       Date:  1994-07

7.  Wide-field capillary microscopy.

Authors:  H R Maricq
Journal:  Arthritis Rheum       Date:  1981-09

8.  Cutaneous and serologic subsets of systemic sclerosis.

Authors:  C Ferri; L Bernini; R Cecchetti; A Latorraca; G Marotta; G Pasero; R Neri; S Bombardieri
Journal:  J Rheumatol       Date:  1991-12       Impact factor: 4.666

9.  Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.

Authors:  C G Kallenberg; G W Pastoor; A A Wouda; T H The
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103
  9 in total
  1 in total

Review 1.  Calcium channel blockers for primary Raynaud's phenomenon.

Authors:  Holly Ennis; Michael Hughes; Marina E Anderson; Jack Wilkinson; Ariane L Herrick
Journal:  Cochrane Database Syst Rev       Date:  2016-02-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.